Document Detail

Robust reference intervals for liver function test (LFT) analytes in newborns and infants.
Jump to Full Text
MedLine Citation:
PMID:  22958834     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Reference intervals (RIs) are ranges of upper and lower limits of a given analyte which are used for a laboratory test to determine whether a disease is present or absent or to know if the patient is at risk for future disease states. In Ethiopia, a country with highly diversified population groups and geographical sites, there are no established RIs to metabolic analytes including the liver function test (LFT) analytes for the pediatric population though it has been known that liver function assessment in this population is vital as a result of varied vulnerability to both endogenous and xenobiotic substances.
METHODS: A cross sectional study was conducted in Tikur Anbessa Specialized Hospital (TASH) and Teklehaymanot Health Center (THC) from November 2010 to April 2011. 117 cord blood (from newborns) and venous blood samples (from infants) were collected and analyzed using HumaStar 300. All pre-analytical, analytical and post-analytical aspects were thoroughly controlled. A robust, CLSI/ IFCC recommended, method was used for the determination of upper and lower end points covering 95% of the reference values of each analyte with respective 90% CIs using MedCalc® software.
RESULTS: Combined RIs for newborns and infants were established for albumin, AST, ALP, direct bilirubin and total bilirubin to be 3.88-5.82 g/dl, 16.1-55.4U/l, 130-831U/l, <0.41 mg/dl and <1.37 mg/dl respectively. But, separated RIs were indicated for ALT and GGT as 1.2-23.1U/l and 6.94-24.8U/l ALT; and 30.6-160.7U/L and 10-28.2U/l GGT for newborns and infants respectively. Some maternal and infantile factors were identified to affect the values of analytes.
CONCLUSION: Almost all analytes were different from previously reported values for other target population of similar age group, kit insert values and adult values. So, interpretation of values of these analytes in newborns and infants of Ethiopian population sounds better to be performed by using such RIs taking the effect of some maternal and infantile factors in to account.
Mulugeta Melkie; Mahilet Yigeremu; Paulos Nigussie; Shawel Asrat; Tatek Gebreegziabher; Tilahun Teka; Samuel Kinde
Related Documents :
17235034 - Survival analysis from birth to slaughter of ripollesa lambs under semi-intensive manag...
20181024 - A prospective study of the effect of delivery type on neonatal weight gain pattern in e...
24557834 - Is economic inequality in infant mortality higher in urban than in rural india?
12445154 - Weight and weight gain at 4 months (the netherlands 1998): influences of nutritional pr...
3883714 - Clinical course of fetal hydrocephalus: 40 cases.
2705804 - Outcome of neonatal necrotising enterocolitis: results of the bapm/cdsc surveillance st...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-09-07
Journal Detail:
Title:  BMC research notes     Volume:  5     ISSN:  1756-0500     ISO Abbreviation:  BMC Res Notes     Publication Date:  2012  
Date Detail:
Created Date:  2013-02-06     Completed Date:  2013-06-21     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101462768     Medline TA:  BMC Res Notes     Country:  England    
Other Details:
Languages:  eng     Pagination:  493     Citation Subset:  IM    
Department of Medical Laboratory Science, Arbaminch University, Arbaminch, Ethiopia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Continental Ancestry Group
Alanine Transaminase / blood
Alkaline Phosphatase / blood
Aspartate Aminotransferases / blood
Bilirubin / blood
Community Health Centers
Cross-Sectional Studies
Fetal Blood / chemistry*
Infant, Newborn
Liver Function Tests / standards*
Reference Values
Serum Albumin / analysis
gamma-Glutamyltransferase / blood
Reg. No./Substance:
0/Serum Albumin; 635-65-4/Bilirubin; EC; EC Aminotransferases; EC Transaminase; EC Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): BMC Res Notes
Journal ID (iso-abbrev): BMC Res Notes
ISSN: 1756-0500
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2012 Melkie et al.; licensee BioMed Central Ltd.
Received Day: 27 Month: 1 Year: 2012
Accepted Day: 31 Month: 8 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 7 Month: 9 Year: 2012
Volume: 5First Page: 493 Last Page: 493
PubMed Id: 22958834
ID: 3564864
Publisher Id: 1756-0500-5-493
DOI: 10.1186/1756-0500-5-493

Robust reference intervals for Liver function test (LFT) analytes in newborns and infants
Mulugeta Melkie1 Email:
Mahilet Yigeremu2 Email:
Paulos Nigussie3 Email:
Shawel Asrat2 Email:
Tatek Gebreegziabher4 Email:
Tilahun Teka2 Email:
Samuel Kinde2 Email:
1Department of Medical Laboratory Science, Arbaminch University, Arbaminch, Ethiopia
2Faculty of Medicine, Addis Ababa University, Addis ababa, Ethiopia
3Ethiopian Health and Nutrition Research Institute, Addis Ababa, Addis ababa, Ethiopia
4Tikur Anbessa Specialized Hospital, Addis Ababa, Addis ababa, Ethiopia


It is well known that reference intervals (RIs) depend on many factors including the type of instrument and reagents used, the principle or method for the test that is being performed, the type of population being served and the strength of quality assurance practiced at the laboratories [1]. Hence, establishing RIs continued to be a major concern in many parts of the world since the RIs in-use were established mainly for the Caucasian population, and are often inappropriate for the diverse population that many laboratories serve, and existing RIs need to be verified or validated as they were established decades ago with methods and instrumentations that are now obsolete [2]. Moreover, establishment of RIs is becoming one agenda in assurance of quality with in clinical laboratories [3,4].

In Ethiopia, a country with highly diversified population groups and geographical sites, there are no established RIs for metabolic analytes including the liver function test (LFT) analytes for the pediatric population although some efforts have been initiated for the adult population [5]. It has been known that liver function assessment in pediatric population is vital since there is varied vulnerability to both endogenous and xenobiotic substances which is resulted from developmental changes in the liver’s metabolic activity. Prolonged action of drugs in newborns is attributed to the decreased capacity of the liver to metabolize, detoxify and excrete xenobiotics. Neonatal jaundice is also resulted because of decreased capacity of glucuronide conjugation [6]. As a result, clinicians and researchers have been adopting RIs from textbooks and package inserts that were originally established based on Caucasian population for the interpretation of pediatric laboratory results though it is known that using non-Ethiopian RIs may be misleading.

The purpose of this study is then to establish RIs for the commonly requested LFT analytes in Ethiopian newborns and infants (≤ 1 year) and to determine the effect of selected demographic variables on the values of these analytes.

Method and materials

A cross sectional study was conducted in Tikur Anbessa Specialized Hospital (TASH), department of Obstetrics and Gynecology (OBGY) and Teklehaymanot Health Center (THC) from November 2010 to April 2011. Newborns delivered in OBGY department of TASH with over 37 weeks of gestation, ≥2500 g birth weight and no history of fetal problems were enrolled in the study and their cord blood was collected. Preterm newborns, newborns with <2500 g birth weight, newborns requiring intensive resuscitation and care, newborns from mothers with documented ante- and/or intra-partum complications (gestational diabetes, HIV, hepatitis B/C, eclampsia, etc.) were excluded. Similarly, infants coming for immunization to THC without any organic diseases or other diseases that can alter their biochemical profile and those with weights > 2700 g were included in the study and venous blood was collected. Infants that have organic diseases and other diseases that alter their biochemical profile were excluded from the study. Infants who have taken medications that can affect their biochemical profile were also excluded from the study. Structured questionnaires were used in both cases for the collection of selected demographic information.

The proposal of this study was reviewed by the Department of Medical Laboratory Sciences research review committee and by the Institutional Review Board (IRB) of Addis Ababa University, Faculty of Medicine. Informed (written) consent was obtained from mothers before specimen and data collection.

The pre-analytical, analytical and post-analytical phases of the analyses were controlled throughout the study. Moreover, a pilot study was conducted before the actual data collection. HumaStar 300 analyzer (Human diagnostics worldwide, Germany) was used for laboratory analyses and the methods applied for determination of analytes are summarized in Table 1.

The data obtained from the analyzer and the questionnaires were entered in Microsoft excel sheet and analyzed by MedCalc® software Version 12.1.3. Tukey test and D’Agostino-Pearson (DAP) test were used to detect outlier values and to determine normality of distributions of analyte values respectively. The effects of different variables on the values of the analytes were determined through ANOVA and independent sample t-test. Then, the upper and lower end points covering 95% of the reference value of the analytes were determined with their respective 90% confidence intervals (CIs) by using the robust method, according to the IFCC/CLSI recommendation [13]. Haris and Boyd rule was applied to determine whether partitioning of RIs should be done.

Analytical performance of the methods

The maximum intra-assay coefficients of variations detected (CVs) were 4.15% and 4.31% for normal and pathological control sera respectively. Similarly, the maximum inter-assay CVs were 3.31% and 4.95% for normal and pathological control sera respectively (Table 2). Commercial quality control sera (HUMATROL N and P) were included in every session of analyses. LJ charts were then plotted and all the quality control results were in the acceptable limits.

Demographic data of study participants

A total of 117 study participants that fulfill the inclusion criteria were included in this study among which 60 (51.3%) were newborns and 57 (48.7%) were infants. Overall, male study participants accounted for 53.8% where as females accounted for 46.2%. Summary of the other selected demographic variables is presented in Tables 3 and 4.

RI calculations for the LFT analytes

According to Tukey test, no outlier values were detected in all the studied analytes; and according to the DAP test, all the data were normally distributed/ were found to be normally distributed after logarithmic transformation.

All of the LFT analytes were different in newborns and infants though only ALT and GGT required separated RIs (Figure 1). The combined RIs (for newborns and infants) of AST, ALP, direct bilirubin, total bilirubin and albumin were 16.1-55.4 U/L, 130–831 U/L, below 0.41 mg/dl, below 1.37 mg/dl and 3.88-5.82 g/dl respectively. The separated RIs of ALT were calculated to be 1.2-23.1 U/L and 6.94-24.8 U/L for newborns and infants respectively; while the separated RIs of GGT were determined to be 30.6-160.7 U/L and 10–28.2 U/L respectively.

Maternal alcohol consumption during the periods of gestation was the only factor that affected the values of some LFT analytes (AST and ALP) in newborns (Table 5). But in infants, age group, gender and feeding practice influenced the values of some of LFT analytes (Table 6). Some of the effects were even strong enough to statistically dictate separated RIs.

Up on comparison of the RIs obtained from this study (Table 7) with previously reported values of similar age group, visually significant differences were seen. The values were also different from respective adult values determined for adult Ethiopian population (Table 8).


This study showed that the activity of AST in newborns was higher than in infants (p = 0.026, Figure 1a) even though separated RI was not justifiable according to Harris and Boyd rule. The increment could be due to the release of placental AST in to fetal circulation [17]. Both the upper and lower limits of this RI were similar to the previously reported values of the same age group population and to adult values. But, both upper and lower limits were higher than those provided in manufacturer kit inserts. Though the RI given on manufacture kit inserts lack traceability, it is clearly seen that the values are lower even than values given for adult let alone the pediatric population (Table 8).

According to Elinav et al., there is a significant association between age and serum ALT activity in which a characteristic inverted ‘U’ curve pattern is attained by ALT with age i.e. it increases up to 40–55 years and then decreases [24]. Accordingly, slightly lowered activity of ALT was found in newborns (Figure 1b) that necessitated separated RIs. This can be explained in the view that the fetus in normal physiological circumstances is dependent on the mother for frequent supply of glucose without a significant need of glucose production by gluconeogenesis [25]. But during infancy, there is increased gluconeogenesis and as a result the key enzyme in this process which converts alanine in to alpha ketoglutarate at the initial step, ALT, is increased [26]. The RIs determined for ALT were generally lower than values provided for children up to 3 years of age and adults (Table 8) which could be due to age difference, while they were comparable with cord blood values given in literature.

It has been documented that serum ALP activity can increase up to six times the upper reference limit of adult values during infancy and childhood, which then decreases to attain adult values by the age of 16–20 years the predominating isoenzyme being of bone origin [27]. Significant increment of ALP activity is detected in infants over newborns (p = 0.0001, Figure 1d) without a need for separated RIs. This RI was different from published values for similar age group population and adult population; particularly, the upper limit of the RI was higher (Table 8). As explained by Lucas et al., increased ALP activity might be related to slower growth rate [28].

Despite the fact that the increased activity is neither having any known clinical significance nor resulted from any fetal forms of the enzyme besides indicating immaturity [29], the activity of GGT was higher in newborns (p < 0.0001, Figure 1c) than in infants. In newborns, GGT activity may reach up to 5–7 times the upper limit of normal for adults [30]. The difference also required separated RIs. The RI of newborns was narrower than the value provided by Perkins et al. [18] in which the upper limit was almost a double of the current study while the lower limit was nearly equivalent. But, RI for infantile GGT activity was higher than the value given for children up to 3 years of age (Table 8) while the RI, more specifically, the upper limit was significantly lower than adult values as adults are known to have raised serum GGT activity induced from many factors including alcohol consumption [31].

As shown in Figure 1e and 1f, both direct and total bilirubin values were higher in cord blood than in infants (p = 0.0067 and p < 0.0001 respectively) although the differences failed to illustrate separated RIs. The increment in cord blood bilirubin could be resulted since only infants higher than 1 month of age were included in this study. Moreover, red cell degradation may be initiated in the fetus before delivery. The abrupt interruption in the net influx of bilirubin across the placenta from the fetus to the mother may also lead to further increase in the cord bilirubin [32]. The direct bilirubin RI was higher than values given in literature and manufacturer kit inserts (Table 8) but lower than values indicated for adult population. Similarly, the RI of total bilirubin was higher than values given for children and adults. But, it was significantly lower than values provided by manufacture kit inserts for newborns.

In this study, statistically significant variations were detected regarding albumin (p = 0.0002) values among newborns and infants (Figure 1g) even though the Harris and Boyd test failed to denote separated RIs. The slightly decreased concentration of albumin in newborns may not fully be explained by decreased synthesis as a result of liver immaturity since they are capable of endogenous albumin production even from early pregnancy on [33,34]. As a result, it could also be originated from other factors that govern albumin level like increased degradation, intravascular space and transcapillary escape [35,36]. The lower limit of albumin in newborns and infants was higher than that given in literature (Table 8) for these populations, but it was comparable to the adult values and kit inserts values except that it was lower than the values given for adult Ethiopian population. In contrast, the upper limit was higher than all the comparators used apart from the fact that it was lower than adult values determined in Ethiopia.

It has been indicated that a cord blood albumin value of >3.3 g/dl [37] and bilirubin value of <1.75 mg/dl [38] are presumed as safe levels in which there is minimal chance of neonatal jaundice. But, in this study, even the minimum value of albumin was higher than the aforementioned one. However, it needs further study to ascertain whether our newborns are really safe from subsequent occurrence of neonatal jaundice at the provided albumin level.

Maternal alcohol consumption during the periods of gestation was found to affect the values of AST (p = 0.003) and ALP (p = 0.011). The AST values were higher while ALP values were lower in newborns from mothers consuming alcohol during the period of gestation with separated RIs indicated for both variations (Table 7). These results need further investigation using increased sample sizes since the actual number of mothers consuming alcohol during the periods of gestation was actually 11 in this study.

In the infantile population, age dependent variation of ALP (p = 0.002) and GGT (p = 0.000) activity was detected in which the activities of both enzymes were higher in infants of age below 6 months though only the variation in GGT needed separated RI. The activity of GGT has been reported to decline in the postnatal periods reaching adult values by the age of 5–7 months [30]. Since majority of the infants below 6 months of age were on exclusive breast feeding, the increased GGT activity could partly be explained by absorption of maternal GGT mixed with breast milk [39].

Sex dependent variation of ALT was also revealed in which the activity of this enzyme is slightly higher in females with separated RIs indicated. Though separated RI is not indicated, ALP activity tended to be lower in infants on additional food to breast feeding. Albumin also showed age dependent variation in infants with separated RIs (Table 7). Infants of age group above 6 months were having higher values of albumin (p = 0.001) as a result of gradual increment through age [19].


Even though all LFT analytes showed difference in newborns and infants, ALT and GGT activities only necessitated separated RIs. Some infantile and maternal factors like age, sex, feeding practice and maternal alcohol consumption during gestational periods were important factors that affected the values of analytes in serum of newborns and infants.

Almost all LFT analytes were different from previously reported values for other target population of similar age group, kit insert values and RIs given for adult populations. Hence, interpretation of LFT analytes in Ethiopian pediatric population sounds better to be performed by using such RIs taking the effect of infantile and maternal factors in to account.

Competing interests

The authors declared no competing interests in this research. In fact, the research was financially supported by Addis Ababa University; and other non-financial supports were also obtained from Mesroy international plc (Reagents) and Medcalc Software Company (statistical software).

Authors' contributions

MM, TT and SK have participated in the conception and design of the study. MY and TT have participated in the selection of study participants. MM, PN, SA and TG have participated in the laboratory analysis and acquisition of data. MM, TT, MY and SK have participated in preparing and critically reviewing the draft manuscript. All authors have read and approved the final manuscript.


The authors would like to thank Addis Ababa University for the financial support, Mesroy international plc and International clinical laboratories for their reagent and sample collection material supply, and Medcalc Software Company for their support in providing us statistical software for free.

Norbert WT WTC,Esther FF,John FK,Howard MR,Fundamentals of Clinical ChemistryYear: 19822USA: W.B. Saunders Company
Aytekin M,Emerk K,Accurate Reference Intervals Are Required For Accurate Diagnosis and Monitoring of PatientseJIFCCYear: 2008192
International Organization for Standardization document ISO 15189:2007. Medical laboratories—Particular requirements for quality and competence2Geneva Stage: 90.92/TC212, ICS: 03.120.10; 11.100.01.
Concordet D,Geffré A,Braun JP,Trumel C,A new approach for the determination of reference intervals from hospital-based dataClin Chim ActaYear: 2009405434819351531
Kinde S,Worku Y,Ayana G,Kuewku Y,Engers H,Assefa A,Establishment of Biochemical Reference Values of Commonly Requested Liver Function Tests for Apparently Healthy Ethiopian Medical StudentsEPHAYear: 2010 20th annual conference.
Piñeiro-Carrero VM,Piñeiro EO,LiverPediatricsYear: 200411341097110615060205
Schumann G,Bonora R,Ceroitti F,Ferard G,Ferrero CA,Franck PFH,et al. IFCC primary reference procedures for the measurement of enzymes at 37°C: Part 5; Reference procedure for the measurement of catalytic concentration of Aspartate AminotransferaseClin Chem Lab MedYear: 20024072573312241022
Schumann G,Bonora R,Ceroitti F,Ferard G,Ferrero CA,Franck PFH,et al. IFCC primary reference procedures for the measurement of enzymes at 37°C: Part 4; Reference procedure for the measurement of catalytic concentration of Alanine AminotransferaseClin Chem Lab MedYear: 20024071872412241021
Schumann G,Bonora R,Ceroitti F,Ferard G,Ferrero CA,Franck PFH,et al. IFCC primary reference procedures for the measurement of enzymes at 37°C: Part 6; Reference procedure for the measurement of catalytic concentration of γ- glutamyltransferasesClin Chem Lab MedYear: 20024073473812241023
Bowers GN,McComb RB,A continuous spectrophotometric method for measuring the activity of serum alkaline phosphataseClin ChemYear: 19661270894952423
Burtis CA,Ashwood ER,Bruns DE,TIETZ Textbook of Clinical Chemistry and Molecular diagnosticsYear: 20064USA: Elsevier Inc
Douinas BT,Watson WA,Biggs HG,Albumin standards and the measurement of serum albumin with bromcresol greenClin Chim ActaYear: 197131875544065
Clinical and Laboratory Standards Institute (CLSI)Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline –Third Edition. CLSI document C28-A3 (ISBN 1-56238-682-4). CLSI, 940 West Valley Road, Suite 1400Year: 2008Pennsylvania 19087–1898 USA: Wayne
Human Diagnostic kit inserts. Bilirubin D liquicolor Photometric Test for Direct Bilirubin and Total Bilirubin Modified Jendrassik/Gróf MethodYear: 2010 Available online at
Human Diagnostic kit inserts. Albumin liquicolor Photometric Test for Albumin BCGMethodYear: 2010 Available online at
Karita E,Ketter N,Price MA,Kayitenkore K,Kaleebu P,Nanvubya A,Anzala O,Jaoko W,Mutua G,Ruzagira E,Mulenga J,Sanders EJ,Mwangome M,Allen S,Bwanika A,Bahemuka U,Awuondo K,Omosa G,Farah B,Amornkul P,Birungi J,Yates S,Stoll-Johnson L,Gilmour J,Stevens G,Shutes E,Manigart O,Hughes P,Dally L,Scott J,Stevens W,Fast P,Kamali A,CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern AfricaPLoS OneYear: 200942e440119197365
Knapen MFCM,Van der Wildt B,Sijtsma EG,Peters WHM,Roelofs HMJ,Steegers EAP,Glutathione S-transferase Alpha 1–1 and aminotransferases in umbilical cord bloodEarly Hum DevYear: 19995412913510213291
Perkins SL,Livesey JF,Beicher J,Reference Intervals for 21 Clinical Chemistry Analytes in Arterial and Venous Umbilical Cord BloodClin ChemYear: 1993396104110448504535
Lockitch G,Halstead AC,Albersheim S,MacCallum C,QuIgIey G,Age- and Sex-Specific Pediatric Reference Intervals for Biochemistry Analytes as Measured with the Ektachem-700 AnalyzerClin ChemYear: 1988348162216253402068
Human Diagnostic kit inserts. GOT (ASAT) IFCC mod. liquiUV Test Aspartate Aminotransferase (EC Available online atYear: 2010
Human Diagnostic kit inserts. GPT (ALAT) IFCC mod. LiquiUV Test Alanine Aminotransferase (EC 2010 Available online at
Alkaline Phosphatase liquicolor DEA Buffer, DGKC Orthophosphoric Monoester Phosphohydrolase (Alkaline Optimum) (EC 2010 Available online at
Human Diagnostic kit inserts. γ-GT liquicolor Colorometric Test L-γ- Glutamyl Transferase (EC 2010 Available online at
Elinav E,Ben-Dov IZ,Ackerman E,Kiderman A,Glikberg F,Shapira Y,Ackerman Z,Correlation Between Serum Alanine Aminotransferase Activity and Age: An Inverted U Curve PatternAm J GastroenterolYear: 20051002201220416181369
Kalhan S,Parimi P,Gluconeogenesis in the fetus and neonateSemin PerinatolYear: 20002429410610805165
Le Couteur DG,Blyth FM,Creasey HM,Handelsman DJ,Naganathan V,Sambrook PN,Seibel MJ,Waite LM,Cumming RG,The Association of Alanine Transaminase with Aging, Frailty, and MortalityJ Gerontol A Biol Sci Med SciYear: 201065771271720498223
Moss DW,Alkaline Phosphatase lsoenzymes: ReviewClin ChemYear: 19822810200720166751596
Lucas A,Brooke G,Baker BA,Bishop N,Morley R,High alkaline phosphatase activity and growth in preterm neonatesArch Dis ChildYear: 1989649029092774631
Allen KJ,Wassef SY,Tebbett IR,Covert RF,Whitington PF,Fetal Gender and Cocaine Exposure as Determinants of Cord Blood Gamma-Glutamyl Transferase ActivityJ PerinatolYear: 20022213313611896518
Cabrera-Abreu JC,Green A,Glutamyltransferase: value of its measurement in paediatrics; Review ArticleAnn Clin BiochemYear: 200239222511853185
Whitfield JB,Gamma Glutamyl TransferaseCrit Rev Clin Lab SciYear: 200138426335511563810
Stevenson DK,Dennery PA,Hintz SR,Understanding Newborn JaundiceJ PerinatolYear: 200121S21S2411803411
Van den Akker CHP,Schierbeek H,Rietveld T,Vermes A,Duvekot JJ,Steegers EAP,Goudoever JB,Human fetal albumin synthesis rates during different periods of gestationAm J Clin NutrYear: 200888997100318842786
Van den Akker CHP,Van Goudoever JB,Recent advances in our understanding of protein and amino acid metabolism in the human fetusCurr Opin Clin Nutr Metab CareYear: 201013758019904202
Cartlidge PHT,Rutter N,Serum albumin concentrations and oedema in the newbornArch Dis ChildYear: 1986616576603740904
Bunt JEH,Rietveld T,Schierbeek H,Wattimena JLD,Zimmermann LJI,van Goudoever JB,Albumin synthesis in preterm infants on the first day of life studied with [1-13C] leucineAm J Physiol Gastrointest Liver PhysiolYear: 2007292G1157G116117234894
Sahu S,Abraham R,John J,Mathew AA,George AS,Cord blood albumin as a predictor of neonatal jaundiceInt J Biol Med ResYear: 201121436438
Pfer MK,Pulzer F,Gebauer C,Robel-Tillig E,Vogtmann C,Predictive value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemiaActa PaediatrYear: 20059458158716188747
Moniz C,Nicolaides KH,Keys D,Rodeck CH,Ƴ-glutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestationClin PatholYear: 198437700703


[Figure ID: F1]
Figure 1 

Box and Whisker plots indicating the difference among newborns and infants in values of AST (a), ALT (b), GGT (c) ALP (d), direct bilirubin (e), total bilirubin (f) and albumin (g).

[TableWrap ID: T1] Table 1 

Summary of test methods applied for each analyte

LFT analytes Analytical method
Aspartate aminotransferases (AST)
IFCC Modified method, 37oC [7]
Alanine aminotransferases (ALT)
IFCC Modified method, 37oC [8]
γ- glutamyltransferases (GGT)
γ-glutamyl-p-nitroanilide substrate [9]
Alkaline Phosphatase (ALP)
Optimized standard method [10]
Bilirubin (Direct + Total)
Modified Jendrasic/Grof method [11]
Albumin BCG method [12]

LFT = Liver function tests, IFCC = International federation for Clinical Chemistry, BCG = Bromocresol green.

[TableWrap ID: T2] Table 2 

Intra- and inter assay CVs determined from duplicate analysis of quality control sera (HUMATROL N and P) for LFT analytes

  Analytes Intra assay CVs
Inter assay CVs
Normal control Pathological control Normal control Pathological control
Direct Bilirubin
Total Bilirubin
Albumin 0.89% 0.89% 3.07% 2.46%

CVs = Coefficient of variations, LFT = Liver function tests, N = normal, P = pathological, AST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase.

[TableWrap ID: T3] Table 3 

summary of the distribution of selected demographic variables among newborns and infants

Demographic variables Newborns (n = 60) Infants (n = 57) p-value
x– = 50.9 cm SD = 3.1 cm
x– = 60.5 cm SD = 8.5 cm
x– = 3120.0 g SD = 411.7 g
x– = 6956.1 g SD = 1996.2 g
Head circumference
x– = 35.3 cm SD = 3.1 cm
x– = 43.7 cm SD = 3.3 cm
Mode of deliveries
Normal vaginal delivery
n = 43 (71.7%)
Cesarean section
n = 17 (28.3%)
n = 32 (46.7%)
n = 31 (54.4%)
P = 0.9431§
n = 28 (53.3%)
n = 26 (45.6%)
Maternal educational level
Unable to write and read
n = 7 (11.7%)
n = 7 (12.3%)
Below 8th grade
n = 22 (36.7%)
n = 34 (59.6%)
P = 0.0380§
High school complete
n = 16 (26.7%)
n = 11 (19.3%)
Certificate and above
n = 15 (25%)
n = 5 (8.8%)
Maternal occupation
House wives
n = 41(68.3%)
n = 18 (31.6%)
n = 10 (16.7%)
n = 7 (12.3%)
P < 0.0001§
Private business
n = 7 (11.7%)
n = 9 (15.8%)
n = 2 (3.3%)
n = 23 (40.4%)
Maternal parity
n = 39 (65%)
n = 27 (47.4%)
P = 0.0826§
n = 21 (35%)
n = 30 (52.6%)
Maternal alcohol consumption
n = 11 (18.3%)
n = 2 (4.3%)
P = 0.0605§
n = 49 (81.7%)
n = 44 (95.7%)
Maternal chat chewing
n = 0 (0%)
n = 3 (6.5%)
P = 0.1568§
n = 60 (100%)
n = 43 (93.5%)
Maternal cigarette smoking
n = 0 (0%)
n = 0 (0%)
P = 0.2067§
No n = 60 (100%) n = 57 (100%)  

§ chi-square test, NA = not available, n = number, cm = centimeter, g = gram, x– = mean, SD = standard deviation.

[TableWrap ID: T4] Table 4 

Summary of feeding practice in infants of different age groups

Age groups
Breast milk only
Formula milk only
Combination of breast and formula milk
Additional foods
< 6 months
22 (78.6%)
2 (7.1%)
4 (14.3%)
0 (0.0%)
28 (49.1%)
> 6 months
7 (24.1%)
9 (31.0%)
7 (24.1%)
6 (20.7%)
29 (50.9%)
   Total 29 (50.9%) 11 (19.3%) 11 (19.3%) 6 (10.5%) 57 (100%)

[TableWrap ID: T5] Table 5 

Results of independent sample t-tests(p-values) which were performed to see effect of maternal and neonatal factors on the values of LFT analytes in newborns

Analyte Variables
Sex Maternal parity Mode of delivery Maternal alcohol consumption Harris and Boyd
Separate RI
No separate RI
Separate RI
No separate RI
Direct bilirubin
No separate RI
Total bilirubin
No separate RI
Albumin 0.053 0.155 0.158 0.256 No separate RI

LFT = Liver function tests, RI = Reference interval, AST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase.

[TableWrap ID: T6] Table 6 

Results of independent sample t-tests* and ANOVAwhich were performed to see effect of maternal and infantile factors on the values of LFT analytes in infant blood samples

  Analyte Variables
Age group Sex Feeding practice Maternal parity Maternal alcohol consumption Maternal chat chewing Harris and Boyd
No separate RI
Separate RI
No separate RI
Separate RI
Direct bilirubin
No separate RI
Total bilirubin
No separate RI
Albumin 0.001* 0.860* 0.168 0.349* 0.111* 0.759* Separate RI

ANOVA = analysis of variance, LFT = Liver function tests, RI = Reference interval, AST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase.

[TableWrap ID: T7] Table 7 

Summary of the RIs LFT analytes in cord and infant blood samples

Analyte   n Min. value Max. value DAP test Mean (95% CI) Lower limit (90% CI) Upper limit (90%CI) RI
Albumin (g/dl)
P = 0.341
4.84 (4.75-4.93)
3.88 (3.83-3.97)
5.82 (5.71-5.86)
Infants < 6 months  > 6 months
28 29
4.15 4.82
5.45 5.65
P = 0.475 P = 0.463
4.80 (4.66-4.95) 5.30 (5.22-5.39)
4.00 (3.85-4.12) 4.87 (4.72-4.95)
5.59 (5.50-5.76) 5.77 (5.71-5.89)
4.00-5.59 4.87-5.77
AST (U/l)
P = 0.204
35.9 (34.1-37.7)
16.1 (14.7-17.1)
55.4 (53.3-56.5)
Newborns Alcohol Yes  Alcohol No
11 49
34 18
54 53
P = 0.43 P = 0.36
45.5 (40.6-50.4) 36.2 (33.5-38.9)
28.2 (26.4-31.9) 17.4 (14.8-23)
63 (61.5-66.8) 55.7 (54.2-58.1)
28.2-63 17.4-55.7
ALT (U/l)
P = 0.101
12.5 (11.1-13.8)
1.2 (0.08-3.06)
23.1 (21.4-24.8)
Infants Male Female
57 31 26
10 10 10
20 23 26
P = 0.095 P = 0.123 P = 0.435
16.2 (15.1-17.3) 15.1 (13.8-16.4) 17.6 (15.7-19.4)
6.94 (4.92-9.04) 6.5 (5.0-7.7) 7.7 (7.1-9.1)
24.8 (22.9-26) 22.1 [14-17] 27.3 (25.6-29.7)
6.94-24.8 6.5-22.17.7-27.3
ALP (U/l)
P = 0.141
488 (456–520)
130 (112–155)
831 (781–848)
 Alcohol Yes
P = 0.89
291 (241–341)
112 (78–133)
463 (435–513)
 Alcohol No
P = 0.82
385 (346–428)
180 (169–206)
808 (773–874)
GG (U/l)
P = 0.320
96 (87.6-104)
30.6 (27.8-37.3)
160.7 (150–171)
P = 0.272
19 (17.9-20.2)
10 (9.2-12.4)
28.2 (26.8-29.4)
 < 6 months
P = 0.673
21.2 (20–22.4)
14.8 (13.5-15.9)
27.9 (26.6-29.6)
 > 6 months
P = 0.233
17 (15.2-18.7)
6.9 (1.9-8.0)
26.1 (23.5-28.2)
Direct bilirubin (mg/dl)
P = 0.075
0.18 (0.16-0.20)
−0.06 [−0.07]-[−0.04]
0.41 (0.39-0.43)
Below 0.41
Total bilirubin (mg/dl) Combined 117 0.04 1.37 P = 0.130 0.69 (0.62-0.75) −0.01 [−0.01]-[0.02] 1.37 (1.31-1.40) Below 1.37

LFT = Liver function tests, RI = Reference interval, AST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase, n = number, min = minimum, max = maximum, CI = confidence interval, DAP = D’Agostino-Pearson.

[TableWrap ID: T8] Table 8 

Comparing the RIs of LFTs in newborns and infants with values for the same age group and for adults in previous studies and kit inserts

  AST (U/l) ALT (U/l) ALP (U/l) GGT (U/l) Direct bilirubin (mg/dl) Total bilirubin (mg/dl) Albumin (g/dl)
Current study
Newborns = 1.2-23.1
Newborns = 30.6-160.7
Below 0.41
Below 1.37
Infants = 6.94-24.8
Infants = 10–28.2
Perkins et al.[18] (cord blood)
Lockitch et al.[19] (Up to 3 years)
Below 0.12
Kit inserts
Men ≤ 37 [20]
Men ≤ 42 [21]
Children ≤ 15 years  ≤ 644 [22]
Men = 11-61 [23]
≤ 0.25 [14]
At birth ≤ 5 [14]
3.8-5.1 [15]
Women ≤ 31 [20]
Women ≤ 32 [21]
Men = 80–306 [22]
Women = 9–39 [23]
5 days ≤ 12 [14]
Women = 64–306 [22]
1 month ≤ 1.5 [14]
Adults ≤ 1.1 [14]
Adult values 14-60 [16]
8-61 [16]
0.02-0.52 [16]
0.17-2.16 [16]
5.8-8.8 [16]
Men = 10-58 [5]
Men = 6–42 [5]
Men = 109–353 [5]
Men = 8.5-63 [5]
Men = 0.2-1.47 [5]
Men = 0.6-2.3 [5]
Women = 6-45 [5] Women = 4-27.4 [5] Women = 97–294 [5] Women = 6–59 [5] Women = 0.2-1.45 [5] Women = 0.5-1.72 [5]  

RI = Reference interval, LFT = Liver function tests, AST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase.

Article Categories:
  • Research Article

Keywords: Reference intervals, Liver function test, Robust method, Newborns, Infants, Cord blood.

Previous Document:  Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action.
Next Document:  Anti-inflammatory effects of montelukast on smoke-induced lung injury in rats.